Physician

Aparna R Ambay, M.D.

According to 2025 Medicare claims, Aparna Ambay, M.D. (NPI: 1467417899) practices dermatology in the Tampa, FL market, with the plurality of this provider's patient population coming from Pasco, FL. This provider's primary affiliated billing organization is PARTNERS IN MEDICINE & SURGERY, P.A. (NPI: 1265713903; TIN: 611658162) and primary practice location at 33544-6334.

Ambay's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 485 traditional Medicare patients, billed 2,621 HCPCS/CPT codes, and received $230,637 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 752 prescription claims across 330 beneficiaries totaling $160,967 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 30 records totaling $640. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $167,140 to $230,637. Similarly, Part D prescription costs have moved sharply higher in recent years, from $14,285 to $160,967. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	286	1,677	$167,140
2016	346	2,275	$167,873
2017	381	2,365	$171,192
2018	479	2,941	$216,749
2019	537	3,678	$278,877
2020	384	2,441	$204,838
2021	375	2,156	$213,380
2022	438	2,547	$227,148
2023	471	3,310	$302,437
2024	485	2,621	$230,637

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	92	179	$14,285
2016	73	131	$30,700
2017	101	223	$59,857
2018	137	298	$16,955
2019	185	437	$14,950
2020	200	523	$13,832
2021	222	473	$11,760
2022	256	547	$15,375
2023	280	589	$17,534
2024	330	752	$160,967

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	166	222	$95
17110	Destruction of skin growth, 1-14 growths	123	141	$74
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	287	418	$65
17000	Destruction of precancer skin growth, 1 growth	181	229	$36
17003	Destruction of precancer skin growth, 2-14 growths	133	737	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	39	1,144	$2,708
Doxycycline Hyclate	Doxycycline Hyclate	208	1,991	$1,739
Clobetasol Propionate	Clobetasol Propionate	22	585	$1,113
Betamethasone Dipropionate	Betamethasone Dipropionate	31	790	$1,017
Clindamycin Phosphate	Clindamycin Phosphate	20	591	$636

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$640	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aparna R. Ambay, M.D.?

Tedicare shows public-source Medicare data for Aparna R. Ambay, M.D. (NPI 1467417899), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aparna R. Ambay, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aparna R. Ambay, M.D.?

Aparna R. Ambay, M.D. is linked to PARTNERS IN MEDICINE & SURGERY, P.A. (billing NPI 1265713903) in the available physician profile data.

Does Aparna R. Ambay, M.D. have Open Payments data?

Aparna R. Ambay, M.D. has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.